SciELO - Scientific Electronic Library Online

 
vol.14 issue5Present state of Acute Pain Services in AndaluciaLicodocaíne patch for the treatment of CRPS in the arm by transcutaneous block of the brachial plexus: Clinical case author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista de la Sociedad Española del Dolor

Print version ISSN 1134-8046

Abstract

CALDERON, E. et al. Oxycodone in non-oncological chronic pain: Effects on quality of life parameters. Rev. Soc. Esp. Dolor [online]. 2007, vol.14, n.5, pp.346-350. ISSN 1134-8046.

Objectives: To evaluate the effectiveness and safety of controlled reléase oxicodone in mixed pain mixed in patients with non oncológical severe pain, as well as its interference on the pain and quality of life. Material and Methods: Prospective study. 34 patients with mixed pain (nociceptive and neuropáthic). 1 month minimum pain duration. The brief questionnaire for the evaluation of the pain was used (CBD), the interference with functional parameters of quality of life: general activity, mood, walking, work, relationship with other people and sleep. Starting oxicodone controlled reléaselo mg/12 h and rescue analgesia with oxicodone fast reléase 20 mg/day with progressive increase every 15 days until obtaining adapted control of the pain. Acetaminophen 650 mg/6 h was used as associate medication. The patients were evaluated at 30 and 60 days. Results: The average age of our patients was of 69 ± 7 years, the average dose of oxicodone to provide a suitable control of the pain were 37 ± 6 mg to the day. Oxicodone significantly reduce the intensity of severe pain after 30 and 60 days of treatment, and respectively provided a lightening of the pain 48% and 67%. The parameters of sleeping and relationship with the others improved significantly at the end of the study. The most frequent adverse event was constipation (14,7%). Conclusions: Controlled reléase oxicodone 37 mg/day provides a significant reduction in the intensity of severe pain lasting until second month of treatment with an improvement in the of quality of life.

Keywords : Opiate; oxicodone; nononcológical chronic pain; brief questionnaire pain; quality of life.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License